Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc. · Analyst Estimates

Track AKBA — free
$0.42 +0.01 (+3.28%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19 2.75M Avg daily vol (3M) 8.17M

Analyst Estimates

Compare analyst forecasts for Akebia Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-17 06:53 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.20
-0.20
-0.20
1
-0.16
-0.16
-0.16
-0.16
1
1
0
0
Revenue
USD
Publication date not stated
166.50M
172.12M
175.61M
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.46
-0.46
-0.46
1
-0.36
-0.36
-0.36
-0.33
1
1
0
0
Revenue
USD
Publication date not stated
75.30M
96.84M
136.27M
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.08
-0.08
-0.08
1
-0.03
-0.03
-0.03
-0.05
1
1
0
0
Revenue
USD
Publication date not stated
26.80M
32.52M
36.04M
6
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.11
-0.11
-0.11
1
-0.095
-0.095
-0.095
-0.09
1
1
0
0
Revenue
USD
Publication date not stated
18.60M
23.11M
30.50M
4
— — — — — — — —
Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 157 filings 140 filers Visit website Investor relations